乳腺癌、结直肠癌和非小细胞肺癌的生物标志物更新
Biomarker update for breast, colorectal and non-small cell lung cancer.
作者信息
Ross Jeffrey S
机构信息
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208, USA.
出版信息
Drug News Perspect. 2010 Jan-Feb;23(1):82-8. doi: 10.1358/dnp.2010.23.1.1437316.
Abstract
The integration of diagnostics into the selection, administration, dosing and monitoring of the use of anticancer drugs has continued to impact the pharmaceutical industry with particular emphasis on cancers of the breast, colon and lung. An update is given on the biomarkers for these cancers.
摘要
将诊断技术整合到抗癌药物的选择、给药、剂量确定和监测过程中，持续对制药行业产生影响，尤其着重于乳腺癌、结肠癌和肺癌。本文提供了这些癌症生物标志物的最新情况。
Zotero 插件